Valeriote F - Search Results

1

Quantitative measurements of the efficacy of new anti-cancer agents on fresh human AML cells by using multivariate flow analysis.

Nakeff A, KuKuruga MA, Media JE, Valeriote F, Edelstein MB. Nakeff A, et al. Among authors: valeriote f. J Exp Ther Oncol. 1996 Nov;1(6):361-7. J Exp Ther Oncol. 1996. PMID: 9414426

2

Cellular drug action profile paradigm applied to XK469.

Subramanian B, Nakeff A, Media J, Wentland M, Valeriote F. Subramanian B, et al. Among authors: valeriote f. J Exp Ther Oncol. 2002 Sep-Oct;2(5):253-63. doi: 10.1046/j.1359-4117.2002.01040.x. J Exp Ther Oncol. 2002. PMID: 12416029

3

A new paradigm for the development of anticancer agents from natural products.

Subramanian B, Nakeff A, Tenney K, Crews P, Gunatilaka L, Valeriote F. Subramanian B, et al. Among authors: valeriote f. J Exp Ther Oncol. 2006;5(3):195-204. J Exp Ther Oncol. 2006. PMID: 16528970 Free PMC article. Review.

4

Discovery and development of anticancer agents from plants.

Valeriote F, Grieshaber CK, Media J, Pietraszkewicz H, Hoffmann J, Pan M, McLaughlin S. Valeriote F, et al. J Exp Ther Oncol. 2002 Jul-Aug;2(4):228-36. doi: 10.1046/j.1359-4117.2002.01038.x. J Exp Ther Oncol. 2002. PMID: 12416027

5

The small-molecule TNF-alpha modulator, UTL-5g, reduces side effects induced by cisplatin and enhances the therapeutic effect of cisplatin in vivo.

Shaw J, Chen B, Huang WH, Lee AR, Media J, Valeriote FA. Shaw J, et al. J Exp Ther Oncol. 2011;9(2):129-37. J Exp Ther Oncol. 2011. PMID: 21699020

6

Discovery and development of anticancer agents from marine sponges: perspectives based on a chemistry-experimental therapeutics collaborative program.

Valeriote FA, Tenney K, Media J, Pietraszkiewicz H, Edelstein M, Johnson TA, Amagata T, Crews P. Valeriote FA, et al. J Exp Ther Oncol. 2012;10(2):119-34. J Exp Ther Oncol. 2012. PMID: 23350352

7

Inhibition of macromolecular synthesis by cryptophycin-52.

Subramanian B, Nakeff A, Media JE, Wiegand RA, Valeriote FA. Subramanian B, et al. Anticancer Drugs. 2002 Nov;13(10):1061-8. doi: 10.1097/00001813-200211000-00010. Anticancer Drugs. 2002. PMID: 12439340

8

Cryptophycin 1 cellular levels and effects in vitro using L1210 cells.

Foster BJ, Fortuna M, Media J, Wiegand RA, Valeriote FA. Foster BJ, et al. Among authors: valeriote fa. Invest New Drugs. 1998-1999;16(3):199-204. doi: 10.1023/a:1006148127527. Invest New Drugs. 1998. PMID: 10360599

9

In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.

DeNeve W, Valeriote F, Edelstein M, Everett C, Bischoff M. DeNeve W, et al. Among authors: valeriote f. Cancer Res. 1989 Jul 1;49(13):3452-6. Cancer Res. 1989. PMID: 2731167

10

New in vitro screening model for the discovery of antileukemic anticancer agents.

Valeriote F, Corbett T, Edelstein M, Baker L. Valeriote F, et al. Cancer Invest. 1996;14(2):124-41. doi: 10.3109/07357909609018888. Cancer Invest. 1996. PMID: 8597898 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters